Stay updated with breaking news from Hans Preusting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press Release Stockholm, Sweden, December 13, 2023 At the extraordinary general meeting of Mendus AB , reg. no. 556629-1786, , on 13 December 2023 the EGM adopted, inter alia,...
Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13...
Synerkine Pharma, a biopharmaceutical company based in Leiden has successfully secured €5.3M in an extension of its Series A financing.
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: H.C. Wainwright 25th Annual Global Investment Conference New York, USA, September 11-13, 2023 Mendus CEO Erik Manting will participate and present a Company Update at the conference: https://hcwevents.com/annualconference/ Pareto Securities' Annual Healthcare Conference Stockholm, Swe
At the annual general meeting of Mendus AB , reg. no. 556629-1786, on 12 May 2023 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the... | May 12, 2023